{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:35:43Z","timestamp":1764783343115},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,10,11]],"date-time":"2011-10-11T00:00:00Z","timestamp":1318291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,10,11]],"date-time":"2011-10-11T00:00:00Z","timestamp":1318291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1038\/leu.2011.280","type":"journal-article","created":{"date-parts":[[2011,10,11]],"date-time":"2011-10-11T09:38:39Z","timestamp":1318325919000},"page":"824-826","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Development of acute myeloid leukemia with NPM1 mutation, in Ph-negative clone, during treatment of CML with imatinib"],"prefix":"10.1038","volume":"26","author":[{"given":"G","family":"Georgiou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Efthymiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Vardounioti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Boutsikas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M K","family":"Angelopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T P","family":"Vassilakopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M-C","family":"Kyrtsonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Plata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Tofas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Bitsani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Bartzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Pessach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Dimou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Panayiotidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,10,11]]},"reference":[{"key":"BFleu2011280_CR1","doi-asserted-by":"publisher","first-page":"6041","DOI":"10.1200\/JCO.2009.25.0779","volume":"27","author":"M Baccarani","year":"2009","unstructured":"Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J et al. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol 2009; 27: 6041\u20136605.","journal-title":"J Clin Oncol"},{"key":"BFleu2011280_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cancergencyto.2010.08.017","volume":"204","author":"MJ Groves","year":"2011","unstructured":"Groves MJ, Sales M, Baker L, Griffiths M, Pratt N, Tauro S . Factors influencing a second myeloid malignancy in patients with Philadelphia-negative-7 or del(7q) clones during tyrosine kinase inhibitor therapy for chronic myeloid leukemia. Cancer Genet 2011; 204: 39\u201344.","journal-title":"Cancer Genet"},{"key":"BFleu2011280_CR3","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.leukres.2007.01.022","volume":"31","author":"A Pawarode","year":"2007","unstructured":"Pawarode A, Sait SN, Nganga A, Coignet LJ, Barcos M, Baer MR . Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalities. Leuk Res 2007; 31: 1589\u20131592.","journal-title":"Leuk Res"},{"key":"BFleu2011280_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cancergencyto.2008.09.016","volume":"189","author":"P Schafhausen","year":"2009","unstructured":"Schafhausen P, Dierlamm J, Bokemever C, Btuemmendorf TH, Bacher U, Zander AR et al. Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with imatinib. Cancer Genet Cytogenet 2009; 189: 63\u201367.","journal-title":"Cancer Genet Cytogenet"},{"key":"BFleu2011280_CR5","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.leukres.2008.09.021","volume":"33","author":"P Dvorak","year":"2009","unstructured":"Dvorak P, Hruba M, Subrt I . Development of acute myeloid leukemia associated with Ph-negative clone with inv(3)(q21q26) during imatinib therapy for chronic myeloid leukemia. Leuk Res 2009; 33: 860\u2013861.","journal-title":"Leuk Res"},{"key":"BFleu2011280_CR6","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.leukres.2009.08.032","volume":"34","author":"RL Paquette","year":"2010","unstructured":"Paquette RL, Nicoll J, Chalukya M, Gondek L, Jasek M, Sawyers CL et al. Clonal hematopoiesis in Philadelphia chromosome-negative bone marrow cells of chronic myeloid leukemia patients receiving dasatinib. Leuk Res 2010; 34: 708\u2013713.","journal-title":"Leuk Res"},{"key":"BFleu2011280_CR7","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1200\/JCO.2011.35.0371","volume":"29","author":"J Kronke","year":"2011","unstructured":"Kronke J, Schlenk RF, Jensen KO, Tschurtz F, Corbacioglu A, Gaidzik VI et al. Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study group. J Clin Oncol 2011; 29: 2709\u20132716.","journal-title":"J Clin Oncol"},{"key":"BFleu2011280_CR8","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/sj.leu.2403861","volume":"19","author":"A Fabarius","year":"2005","unstructured":"Fabarius A, Giehl M, Frank O, Duesberg P, Hochhaus A, Hehlmann R et al. Induction of centrosome and chromosome aberrations by imatinib in vitro. Leukemia 2005; 19: 1573\u20131578.","journal-title":"Leukemia"},{"key":"BFleu2011280_CR9","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/sj.leu.2403607","volume":"19","author":"U Bacher","year":"2005","unstructured":"Bacher U, Hochhaus A, Berger U, Hiddemann W, Hehlmann R, Haferlach T et al. Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha. Leukemia 2005; 19: 460\u2013463.","journal-title":"Leukemia"},{"key":"BFleu2011280_CR10","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/leu.2009.95","volume":"23","author":"PP Piccaluga","year":"2009","unstructured":"Piccaluga PP, Sabattini E, Bacci F, Agostinelli C, Righi S, Salmi F et al. Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia. Leukemia 2009; 23: 1370\u20131371.","journal-title":"Leukemia"},{"key":"BFleu2011280_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/leu.2010.236","volume":"25","author":"S Soverini","year":"2011","unstructured":"Soverini S, Score J, Iacobucci I, Poerio A, Lonetti A, Gnani A et al. IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis. Leukemia 2011; 25: 178\u2013181.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2011280.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2011280","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2011280.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T14:37:31Z","timestamp":1648737451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2011280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,11]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["BFleu2011280"],"URL":"https:\/\/doi.org\/10.1038\/leu.2011.280","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,11]]},"assertion":[{"value":"11 October 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}